Ranolazine in Diabetics With Stable Ischemic Heart Disease: Greatest Efficacy Related to Greatest Metabolic Stress
J Am Coll Cardiol
.
2017 May 9;69(18):2314-2316.
doi: 10.1016/j.jacc.2017.03.532.
Author
Peter H Stone
1
Affiliation
1
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: pstone@partners.org.
PMID:
28473137
DOI:
10.1016/j.jacc.2017.03.532
No abstract available
Keywords:
chronic angina; coronary artery disease; glucose control; hemoglobin A(1c).
Publication types
Editorial
Comment
MeSH terms
Diabetes Mellitus*
Humans
Myocardial Ischemia*
Percutaneous Coronary Intervention*
Ranolazine
Stress, Physiological
Substances
Ranolazine